Literature DB >> 10986048

Genetic testing should not be advocated as a diagnostic tool in familial forms of dementia.

E A Croes, B Dermaut, T J van Der Cammen, C van Broeckhoven, C M van Duijn.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10986048      PMCID： PMC1287876          DOI： 10.1086/303074

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN： 0002-9297            Impact factor:   11.025


× No keyword cloud information.
  9 in total

1.  High prevalence of pathogenic mutations in patients with early-onset dementia detected by sequence analyses of four different genes.

Authors:  U Finckh; T Müller-Thomsen; U Mann; C Eggers; J Marksteiner; W Meins; G Binetti; A Alberici; C Hock; R M Nitsch; A Gal
Journal:  Am J Hum Genet       Date:  2000-01       Impact factor: 11.025

2.  The Glu318Gly substitution in presenilin 1 is not causally related to Alzheimer disease.

Authors:  B Dermaut; M Cruts; A J Slooter; S Van Gestel; C De Jonghe; H Vanderstichele; E Vanmechelen; M M Breteler; A Hofman; C M van Duijn; C Van Broeckhoven
Journal:  Am J Hum Genet       Date:  1999-01       Impact factor: 11.025

Review 3.  Transmissible spongiform encephalopathies.

Authors:  A M Haywood
Journal:  N Engl J Med       Date:  1997-12-18       Impact factor: 91.245

Review 4.  The genetics of Alzheimer disease: current status and future prospects.

Authors:  D Blacker; R E Tanzi
Journal:  Arch Neurol       Date:  1998-03

5.  Prominent psychiatric features and early onset in an inherited prion disease with a new insertional mutation in the prion protein gene.

Authors:  J L Laplanche; K H Hachimi; I Durieux; P Thuillet; L Defebvre; N Delasnerie-Lauprêtre; K Peoc'h; J F Foncin; A Destée
Journal:  Brain       Date:  1999-12       Impact factor: 13.501

6.  Early-onset autosomal dominant Alzheimer disease: prevalence, genetic heterogeneity, and mutation spectrum.

Authors:  D Campion; C Dumanchin; D Hannequin; B Dubois; S Belliard; M Puel; C Thomas-Anterion; A Michon; C Martin; F Charbonnier; G Raux; A Camuzat; C Penet; V Mesnage; M Martinez; F Clerget-Darpoux; A Brice; T Frebourg
Journal:  Am J Hum Genet       Date:  1999-09       Impact factor: 11.025

7.  Estimation of the genetic contribution of presenilin-1 and -2 mutations in a population-based study of presenile Alzheimer disease.

Authors:  M Cruts; C M van Duijn; H Backhovens; M Van den Broeck; A Wehnert; S Serneels; R Sherrington; M Hutton; J Hardy; P H St George-Hyslop; A Hofman; C Van Broeckhoven
Journal:  Hum Mol Genet       Date:  1998-01       Impact factor: 6.150

Review 8.  Presenilin mutations in Alzheimer's disease.

Authors:  M Cruts; C Van Broeckhoven
Journal:  Hum Mutat       Date:  1998       Impact factor: 4.878

9.  Familial Alzheimer's disease genes in Japanese.

Authors:  K Kamimura; H Tanahashi; H Yamanaka; K Takahashi; T Asada; T Tabira
Journal:  J Neurol Sci       Date:  1998-09-18       Impact factor: 3.181
  9 in total
  2 in total

Review 1.  Genetics of Alzheimer's disease: a centennial review.

Authors:  Nilüfer Ertekin-Taner
Journal:  Neurol Clin       Date:  2007-08       Impact factor: 3.806

2.  Genetic counseling and testing for Alzheimer disease: joint practice guidelines of the American College of Medical Genetics and the National Society of Genetic Counselors.

Authors:  Jill S Goldman; Susan E Hahn; Jennifer Williamson Catania; Susan LaRusse-Eckert; Melissa Barber Butson; Malia Rumbaugh; Michelle N Strecker; J Scott Roberts; Wylie Burke; Richard Mayeux; Thomas Bird
Journal:  Genet Med       Date:  2011-06       Impact factor: 8.822
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.